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cuff pressure of polyurethane-cuffed tracheal
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Alain Durocher1,6, Alain Duhamel7 and Saad Nseir1,6*Abstract
Background: The primary objective of this study was to determine the efficiency of a pneumatic device in
controlling cuff pressure (Pcuff) in patients intubated with polyurethane-cuffed tracheal tubes. Secondary
objectives were to determine the impact of continuous control of Pcuff, and cuff shape on microaspiration
of gastric contents.
Methods: Prospective randomized controlled study. All patients requiring intubation and mechanical
ventilation ≥48 h were eligible. The first 32 patients were intubated with tapered polyurethane-cuffed,
and the 32 following patients were intubated with cylindrical polyurethane-cuffed tracheal tubes.
Patients randomly received 24 h of continuous control of Pcuff using a pneumatic device (Nosten®), and
24 h of routine care of Pcuff using a manometer. Target Pcuff was 25 cmH2O. Pcuff was continuously recorded,
and pepsin was quantitatively measured in all tracheal aspirates during these periods.
Results: The pneumatic device was efficient in controlling Pcuff (med [IQ] 26 [24, 28] vs 22 [20, 28] cmH2O,
during continuous control of Pcuff and routine care, respectively; p = 0.017). In addition, percentage of patients with
underinflation (31% vs 68%) or overinflation (53% vs 100%) of tracheal cuff, and percentage of time spent with
underinflation (0.9 [0, 17] vs 14% [4, 30]) or overinflation (0 [0, 2] vs 32% [9, 54]) were significantly (p < 0.001)
reduced during continuous control of Pcuff compared with routine care.
No significant difference was found in microaspiration of gastric content between continuous control of Pcuff
compared with routine care, or between patients intubated with tapered compared with cylindrical
polyurethane-cuffed tracheal tubes.
Conclusion: The pneumatic device was efficient in controlling Pcuff in critically ill patients intubated with
polyurethane-cuffed tracheal tubes.
Trial registration: The study was registered at clinicaltrial.gov (NCT01351259).
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Microaspiration of contaminated oropharyngeal secre-
tions and gastric content frequently occurs in intubated
critically ill patients, and plays a major role in the patho-
genesis of ventilator-associated pneumonia (VAP) [1].
Aspiration of contaminated secretions is followed by
tracheobronchial colonization that might progress into
VAP depending on quantity, and virulence of microor-
ganisms, and local and general defense mechanisms [2].
During the last decade, significant progress has been
achieved in the field of prevention of microaspiration,
and VAP [3,4]. Polyurethane-cuffed tracheal tubes were
reported to significantly reduce leakage in in vitro stud-
ies, and microaspiration in intubated critically ill patients
[5-7]. In addition, three clinical studies reported signifi-
cant reduction in VAP, and nosocomial pneumonia rate
in patients intubated with polyurethane-cuffed tracheal
tubes compared with those intubated with standard
polyvinyl chloride-cuffed tracheal tubes [8-10]. However,
limitations of these studies, including the use of subglot-
tic aspiration in the intervention group in one study,
clinical definition of nosocomial pneumonia, and before-
after design should be taken into account. Recent data
coming from in vitro studies also suggested a beneficial
effect of tapered-shaped tracheal cuff in reducing micro-
aspiration [11-13].
Underinflation, and overinflation of tracheal cuff are
major risk factors for microaspiration, VAP, and tracheal
injury [14-16]. Despite routine control of cuff pressure
(Pcuff ) using a manometer, patients intubated with
polyvinyl-chloride or polyurethane-cuffed tracheal tubes
spend a large amount of time with underinflation and
overinflation of tracheal cuff [6,17]. Continuous control
of polyvinyl chloride-cuffed tracheal tubes using a
pneumatic device was found to be associated with
significantly reduced microaspiration of gastric content,
and VAP incidence [18]. However, there are several
differences between polyvinyl chloride and polyurethane,
including thickness and physicochemical properties.
Condensation formation in the pilot external balloon is
very frequent in patients intubated with polyurethane-
cuffed tracheal tubes. Whether condensation formation
or other physicochemical properties of polyurethane could
influence the efficiency of a pneumatic device in continu-
ously controlling Pcuff is unknown. To our knowledge, no
study has evaluated the efficiency of a pneumatic or an
electronic device in continuously controlling Pcuff in pa-
tients intubated with polyurethane-cuffed tracheal tubes.
Therefore, we conducted this randomized controlled trial
to determine the efficiency of a pneumatic device in
controlling Pcuff in critically-ill patients intubated with
polyurethane-cuffed tracheal tube compared with routine
care using a manual manometer. The secondary objectives
were to determine the impact of continuous control ofPcuff, and cuff shape, i.e. tapered versus cylindrical, on
microaspiration of gastric content.Methods
The local institutional review board of the Lille University
Hospital approved this study. The patients provided their
written consent before randomization. In unconscious
patients who were not able to give consent for inclusion
in the study at randomization, relatives (next-of-kin)
gave assent on every patient’s behalf, and patients
were later given the opportunity to withdraw from
the study. The study was registered at clinicaltrial.gov
(NCT01351259).Study design
This prospective randomized controlled cross-over study
was conducted in a single 10-bed medical ICU during a
17-month period. Inclusion criteria were age >18 years,
intubation in the ICU, and expected duration of invasive
mechanical ventilation ≥48 hours. Exclusion criteria were
enrolment in another trial, contraindication for semire-
cumbent position or for enteral nutrition, and intubation
before ICU admission.
Primary objective was to determine the efficiency of
a pneumatic device in controlling Pcuff in patients
intubated with polyurethane-cuffed tracheal tubes
compared with routine care using a manual mano-
meter. Secondary objectives were to determine the
impact of continuous control of Pcuff, and cuff shape,
i.e. tapered versus cylindrical, on microaspiration of
gastric contents.
All patients were intubated with polyurethane-cuffed
tracheal tubes. Tracheal tube size was 7.5 and 8 in
women and men, respectively. The first 32 patients were
intubated with a tapered-cuffed tracheal tube (SealGuard®,
Mallinckrodt, Athlone, Ireland), and the 32 following
patients were intubated with a cylindrical-cuffed tracheal
tube (Microcuff®, Kimberly-Clark, Georgia, USA). Patients
were randomly assigned to receive continuous control of
Pcuff for 24 hours followed by routine care for 24 hours, or
routine care for 24 hours followed by continuous control
Pcuff for 24 hours. The target Pcuff was 25 cm H2O during
the two 24-hour periods. A computer-generated random
assignment list in balanced blocks of four was used. Sealed
opaque individual envelopes containing treatment assign-
ments were numbered sequentially. All caregivers were
blinded to the randomization schedule and the block size.
Because of the nature of the intervention, physicians and
nurses could not be blinded to the randomization arm.
However, engineer who performed the analysis of Pcuff
recording (JD) and physicians who performed pepsin
measurement (FZ, and MB) were blinded to study group
assignment.
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Routine care of tracheal cuff was managed according to
an internal procedure adapted from the Société de Réani-
mation de Langue Française recommendations [19]. A
manual manometer (Ambu® Cuff Pressure Gauge, Ambu
A/S, Ballerup, Denmark) was used to check and adjust
Pcuff every 8 hours. Continuous control of Pcuff was
performed using a pneumatic device (Nosten®, Leved,
St-Maur, France) [20].
Outcome measurement
In all patients, Pcuff and airway pressure were continu-
ously recorded (Physiotrace®, CHRU, Lille, France) at a
digitizing frequency of 100 Hz during the 48 hours
following randomization, including 24 hours of continu-
ous control of Pcuff, and 24 hours of routine care. Nurses
were blinded to recording data. Pepsin was quantitatively
measured in all tracheal aspirates during the same two
24-hour periods. In order to avoid overlap in pepsin
results between the two 24-hour periods, tracheal suc-
tioning was always performed at the end of the first
periods of Pcuff control. Tracheal aspirates were stored
at −20°C. Quantitative pepsin measurement was per-
formed by an ELISA technique [18].
Study population
Measures aiming at preventing microaspiration were used
in all patients including protocolized enteral nutrition,
and sedation, minimal positive end expiratory pressure of
5 cm H2O, and semirecumbent position. Continuous
subglottic suctioning was not utilized. Nurses performed
tracheal suctioning every 3 hours or more if clinically indi-
cated, using an open tracheal suction system.
Definitions
The primary end point was the percentage of patients
with underinflation (Pcuff <20 cm) H2O or overinflation
(Pcuff >30 cm H2O) of tracheal cuff. Secondary outcomes
included duration of underinflation and overinflation of
Pcuff, coefficient of variation of Pcuff, and microaspiration
of gastric content. Pcuff continuous recording data were
used to determine the time spent with normal Pcuff,
underinflation, and overinflation of tracheal cuff. The
coefficient of variation of Pcuff was calculated as standard
deviation/mean Pcuff × 100. Microaspiration of gastric
content was defined by the presence of pepsin at signifi-
cant level (>200 ng/mL) in at least one tracheal aspirate.
Statistical analyses
Based on the incidence of underinflation or overinflation of
tracheal cuff in patients intubated with polyurethane-cuffed
tracheal tubes and receiving routine care of Pcuff in our ICU
(70%), we estimated an incidence of underinflation or
overinflation in patients intubated with polyurethane-cuffedtracheal tubes and receiving continuous control of Pcuff of
30%. Randomly assigning 32 patients to two 24-hour
periods of Pcuff control would allow detection of this
difference with 80% power and a two-tailed significance
level of 0.05. To determine the impact of cuff shape on
microaspiration of gastric content, two groups of 32 pa-
tients intubated with tapered or cylindrical-cuffed tracheal
tubes were required.
All P values were two-tailed. Categorical variables were
described as frequencies (%). Because they were not
normally distributed, continuous variables were described
as median (interquartile range). McNemar’s test and
Wilcoxon rank test were used to compare qualitative and
quantitative variables between the two 24-hour periods,
respectively. For comparisons between subgroups (tapered
versus cylindrical-cuffed tracheal tubes), χ2 test or Fisher
exact test were used to compare qualitative variables, and
Mann–Whitney U test was used to compare continuous
variables.
To determine the impact of high airway pressures on
the efficiency of the pneumatic device, we compared the
time spent with underinflation and overinflation of Pcuff
during continuous control of tracheal cuff between
patients with high airway pressures (≥ 75th quartile of
airway pressures in the cohort), and those with lower




Sixty four patients were included in this study, including
32 intubated with tapered-cuffed tracheal tube, and 32
with cylindrical-cuffed tracheal tube. Study flow chart is
presented in Figure 1. Median time from intubation to
randomization was 3 days (1, 7). Median tracheal tube
size was 8 mm (7.5-8). No significant difference was
found in median time from intubation to randomization
(4 [1,8] vs 2 days [1,5]), p = 0.470; or tracheal tube size
(8 [7.5-8] vs 8 mm [7.5-8], p = 0.456) between patients
intubated with tapered-cuffed tracheal tubes and those
intubated with cylindrical-cuffed tracheal tubes, respect-
ively. No significant difference was found in patient
characteristics between the two periods of continuous
control of Pcuff and routine care, or between patients
intubated with tapered-cuffed tracheal tubes, and
those intubated with cylindrical-cuffed tracheal tubes
(Tables 1, and 2).
Continuous control versus routine care of tracheal cuff
The pneumatic device was efficient in controlling Pcuff.
Percentage of patients with underinflation or overinfla-
tion of tracheal cuff, coefficient of variation of Pcuff, and
percentage of time spent with underinflation and overin-
flation of tracheal cuff were significantly lower during
Figure 1 Study flowchart. Pcuff, cuff pressure; P1, period 1; P2, period 2.
Jaillette et al. BMC Anesthesiology 2013, 13:50 Page 4 of 9
http://www.biomedcentral.com/1471-2253/13/50continuous control of Pcuff compared with routine care.
Pcuff, and percentage of time spent with Pcuff 20–30
cmH2O were significantly higher during continuous
control of Pcuff compared with routine control. No sig-




Male gender 43 (67)
SAPS II 45 (32–62)
LOD score 6 (3–9)
Comorbidities
Diabetes mellitus 16 (25)
COPD 23 (35)
Cardiovascular disease 12 (18)
Cirrhosis 1 (1)
Causes for ICU admission
Acute exacerbation of COPD 18 (28)
ARDS 7 (10)
Septic shock 15 (23)
Community-acquired pneumonia 19 (29)
Hospital acquired pneumonia 24 (37)
Congestive heart failure 4 (6)
Neurologic failure 7 (10)
Poisoning 3 (4)
Soft tissue infetion 2 (3)
Data are frequencies (%) or median (Interquartile range).
SAPS, simplified acute physiology score; LOD, logistic organ dysfunction; COPD, chr
Some patients had more than one cause for ICU admission.
*P values are for comparisons of tapered with cylindrical cuff.of gastric content, mean pepsin level, or percentage of
tracheal aspirates positive for pepsin between continuous
control of Pcuff and routine care (Table 3). No significant
interaction was found between continuous control of





66 (58–77) 66 (54–72) 0.330
20 (62) 23 (71) 0.594
45 (29–62) 42 (37–62) 0.289
6 (2–10) 6 (4–9) 0.818
10 (31) 6 (18) 0.386
11 (34) 12 (37) >0.999
7 (21) 5 (15) 0.749
1 (3) 0 >0.999
10 (31) 8 (25) 0.781
3 (9) 4 (12) >0.999
10 (31) 5 (15) 0.238
8 (25) 11 (34) 0.584
16 (50) 8 (25) 0.071
2 (6) 2 (6) >0.999
2 (6) 5 (15) 0.426
2 (6) 1 (3) >0.999
0 2 (6) 0,492
onic obstructive pulmonary disease; ARDS, acute respiratory distress syndrome.
Table 2 Patient characteristics during the 48 hours following randomization























1000 1000 0.433 1000 1000 0.960 1000 1000 0.241
(500–1000) (500–1500) (500–1000) (500–1000) (500–1000) (500–1500)
Gastric residual
volume, ml
0 (0–20) 0 (0–20) 0.871 0 (0–15) 0 (0–27) 0.726 0 (0–60) 0 (0–5) 0.294
Sedation 28 (43) 29 (45) > 0.999 14 (43) 14 (43) >0.999 15 (46) 14 (43) >0.999
Ramsay score 2 (2–3) 2 (2–3) 0.641 2 (2–3) 2 (2–3) 0.718 2 (2–3) 2 (2–3) 0.729
Neuromuscular
blocking agent use
6 (9) 7 (10) > 0.999 3 (9) 3 (9) >0.999 3 (9) 4 (12) >0.999
Glasgow coma score 14 (10–15) 15 (10–15) 0.310 13 (10–15) 14 (8–15) 0.738 14 (10–15) 15 (8–15) 0.908
PEEP 6 (5–8) 6 (5–9) 0.943 6 (5–8) 7 (5–9) 0.234 6 (5–9) 7 (5–9) 0.166
Ventilatory mode 0.329 0.885 0.433
ACV 36 (56) 37 (57) 18 (56) 18 (56) 21 (65) 16 (50)
PSV 23 (35) 25 (39) 11 (34) 12 (37) 10 (31) 15 (46)




Sucralfate 32 (50) 32 (50) 15 (46) 17 (53) 13 (40) 19 (59)
Proton pump
inhibitors
25 (39) 25 (39) 13 (40) 12 (37) 13 (40) 12 (37)
Prokinetic drugs 12 (18) 12 (18) > 0.999 6 (18) 6 (18) >0.999 7 (21) 5 (15) 0.749
Vomiting 3 (4) 1 (1) 0.625 0 3 (9) 0.237 1 (3) 0 >0.999
Head-of-bed position 40 (35–40) 40 (35–40) 0.846 40 (35–45) 40 (35–40) 0.602 40 (35–40) 40 (35–45) 0.244
Data are frequencies (%) or median (Interquartile range).
Pcuff, cuff pressure; PEEP, positive end-expiratory pressure; ACV, assist-control ventilation; PSV, pressure support ventilation; BPPV, bilevel positive pressure ventilation.
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control of Pcuff
During continuous control of Pcuff, percentage of pa-
tients with underinflation of tracheal cuff >30 minutes
was significantly lower in patients intubated with
tapered-cuffed tracheal tubes compared with those intu-
bated with cylindrical-cuffed tracheal tubes. No signifi-
cant difference was found in terms of Pcuff, percentage of
patients with underinflation or overinflation, coefficient
of variation of Pcuff, and percentage of time spent with
underinflation or overinflation between the two groups
during the same period (Table 4).
Tapered versus cylindrical cuff shape during routine care
of Pcuff
During routine care, percentage of time spent with
underinflation of tracheal cuff was significantly higher,
and percentage of time spent with overinflation of
tracheal cuff was significantly lower in patients intubated
with tapered-cuffed tracheal tubes compared with those
intubated with cylindrical-cuffed tracheal tubes. No sig-
nificant difference was found in coefficient of variationof Pcuff, or percentage of patients with underinflation or
overinflation of tracheal cuff between the two groups dur-
ing the same period (Table 4).
Impact of cuff shape on microaspiration
No significant difference was found in microaspiration
of gastric content rate, mean pepsin level or percentage
of tracheal aspirates positive for pepsin between patients
intubated with tapered-cuffed tracheal tubes and those
intubated with cylindrical-cuffed tracheal tubes during
continuous control of Pcuff or routine care (Table 4).
Other results
During continuous control of Pcuff, important condensa-
tion was observed in the pilot balloon in 7 (22%) patients
intubated with tapered-cuffed tracheal tube compared
with 10 (31%) patients intubated with cylindrical-cuffed
tracheal tube (p = 0.571).
No significant difference was found in percentage of
time spent with underinflation (median [IQR] 0.07%
[0.0004-16] versus 0.01% [0.0003-0.6], p = 0.359), or
overinflation of tracheal cuff (6% [0.27-37] versus 0.34%
Table 3 Impact of the pneumatic device on tracheal cuff pressure and microaspiration of gastric content




p OR (95% CI)
Recording duration, h 24 (23–24) 24 (23–24) 0.198
Mean airway pressure, cm H2O 13 (11–18) 13 (11–17) 0.216
Mean Pcuff, cm H2O 26 (24–28) 22 (20–28) 0.017
Coefficient of Pcuff variation, % 5 (3–12) 19 (15–30) <0.001
Pcuff 20-30 cm H2O
yes 64 (100) 64 (100) NA
% of recording time 95 (70–99) 44 (30–59) <0.001
Pcuff <20 or >30, cm H2O
Yes 41 (66) 64 (100) <0.001
Duration >30 min 33 (51) 64 (100) <0.001
Pcuff <20, cm H2O
Yes 19 (29) 60 (93) <0.001 1.46 (1.23-1.73)
Duration > 30 min 16 (25) 57 (89) <0.001 2.63 (1.11-6.21)
% of recording time 0.01 (0–2) 32 (9–54) <0.001
Pcuff >30, cm H2O
Yes 33 (51) 62 (96) 0.001 1.57 (1.10-2.24)
Duration >30 min 25 (39) 54 (84) <0.001 1.50 (1.11-2.20
% of recording time 0.9 (0–17) 14 (4–30) <0.001
Microaspiration of gastric content 32 (50) 38 (59) 0.238
Pepsin, ng/mL 185 (113–296) 203 (120–338) 0.171
% of tracheal aspirates positive for pepsin 29 (0–74) 45 (0–100) 0.162
Data are frequencies (%) or median (Interquartile range). Pcuff, cuff pressure.
Yes indicates that a patient had the variable at least once.
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(n = 16) and those with lower airway pressures (n = 48),
respectively.
Discussion
The percentage of patients with underinflation or over-
inflation of tracheal cuff, percentage of time spent with
underinflation or overinflation of tracheal cuff, and
coefficient of variation of Pcuff were significantly lower
during continuous control of Pcuff compared with routine
care. Further, percentage of time spent with Pcuff 20–30
cmH2O, and mean Pcuff were significantly higher during
continuous control of Pcuff compared with routine care.
However, no significant difference was found in the
incidence of microaspiration of gastric content between
continuous control of Pcuff compared with routine care or
between patients intubated with tapered-cuffed tra-
cheal tubes and those intubated with cylindrical-cuffed
tracheal tubes.
To our knowledge, our study is the first to demonstrate
the efficiency of the pneumatic device in controlling Pcuff
in critically-ill patients intubated with polyurethane-cuffed
tracheal tubes. Previous studies found similar results in
animals and humans intubated with polyvinyl chloride-cuffed tracheal tubes [20,21]. The percentage of patients
with underinflation of tracheal cuff >30 minutes during
continuous control of Pcuff was relatively high (25%). This
could be explained by the physicochemical characteristics
of polyurethane, namely its hydrophilic aspect, resulting
in condensation formation especially during continuous
control of Pcuff. In our study, small condensation for-
mation was rarely observed in the pilot balloon during
routine care of Pcuff. However, important condensation
formation filling the whole pilot balloon was frequently
observed during continuous control of Pcuff. The fact that
evaporation is probably reduced in closed circuit during
continuous control of Pcuff might explain this difference in
condensation formation between routine care and con-
tinuous control of Pcuff. Further studies directly comparing
efficiency of the pneumatic device in polyurethane and
polyvinyl chloride-cuffed tracheal tubes are needed to
confirm our results. Although previous studies have
demonstrated the efficiency of the pneumatic device in
controlling Pcuff in patients intubated with PVC-cuffed
tracheal tubes, the current study allow the generalization
of this observation to patients intubated with polyu-
rethane-cuffed tracheal tubes. Given the growing evidence
supporting the use of polyurethane-cuffed tracheal tubes
Table 4 Impact of cuff shape on cuff pressure and microaspiration during continuous control of cuff pressure and
routine care













Recording duration, h 24 (23–24) 24 (23–25) 0.662 24 (23–25) 24 (23–24) 0.229
Mean airway pressure, cm H2O 13 (10–18) 13 (11–16) 0.749 12 (10–20) 15 (11–15) 0.214
Mean Pcuff, cm H2O 26 (25–28) 25 (23–28) 0.844 21 (19–26) 24 (21–30) 0.143
Coefficient of Pcuff variation, % 5 (3–9) 6 (3–15) 0.382 18 (15–30) 20 (14–39) 0.789
Pcuff 20-30 cm H2O
yes 32 (100) 32 (100) NA 32 (100) 32 (100) NA
% of recording time 97 (82–99) 88 (56–99) 0.147 42 (30–62) 44 (29–57) 0.811
Pcuff <20 or >30 cm H2O
Yes 19 (59) 22 (68) 0.856 32 (100) 32 (100) >0.999
Duration >30 min 14 (43) 19 (59) 0.455 30 (93) 32 (100) >0.999
Pcuff <20 cm H2O
Yes 6 (18) 13 (40) 0.116 29 (90) 31 (96) >0.999
Duration > 30 min 3 (9) 13 (40) 0.011* 29 (90) 28 (87) 0.371
% of recording time 0 (0–0) 0 (0–12) 0.549 41 (17–62) 21 (8–47) 0.049
Pcuff >30 cm H2O
Yes 15 (46) 18 (56) 0.903 31 (96) 31 (96) >0.999
Duration >30 min 12 (37) 13 (40) >0.999 24 (75) 30 (93) 0.235
% of recording time 0.6 (0–24) 1.4 (0–48) 0.652 11 (2–17) 20 (6–18) 0.031
Microaspiration of gastric content 13 (40) 19 (59) 0.211 18 (56) 20 (62) 0.799
Pepsin, ng/mL 154 (105–230) 214 (126–466) 0.066 175 (121–252) 238 (101–664) 0.238
% of tracheal aspirates positive for pepsin 0 (0–57) 43 (0–100) 0.073 40 (0–86) 50 (0–100) 0.310
Data are frequencies (%) or median (Interquartile range).
Pcuff, cuff pressure. Yes indicates that a patient had the variable at least once.
*OR (95% CI) 3.20 (1.12-9.12).
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sary before performing further studies aiming to evaluate
the combined beneficial effects of using polyurethane-
cuffed tracheal tubes and continuous control of Pcuff in
preventing VAP.
In spite of efficient control of Pcuff, no significant
difference was found in microaspiration of gastric con-
tent between continuous control of Pcuff and routine
care. One potential explanation for this result is the
optimal routine care provided during the study, and the
use of polyurethane-cuffed tracheal tubes. These tubes
have been demonstrated to significantly reduce microas-
piration in critically ill patients [5,6]. Further, our study
is probably underpowered to detect such an effect, since
microaspiration of gastric content was a secondary
outcome and the number of included patients was calcu-
lated based on the primary outcome. Further studies are
needed to determine the impact of continuous control
of Pcuff on the incidence of microaspiration, and VAP.
However, whilst our study was underpowered to detect adifference in microaspiration, it was correctly powered
to draw a valuable conclusion on primary outcome, i.e.
the efficiency of the pneumatic device in controlling
Pcuff. In fact, the number of patients required to detect
the estimated difference in percentage of patients with
underinflation or overinflation of Pcuff, with an alpha risk
of 5% and a power of 80%, was 32 per group. As 32
patients were included in each study group, our study is
sufficiently powered to conclude that the pneumatic
device is efficient in controlling Pcuff. This result would
allow future studies to evaluate the impact of the pneu-
matic device on the prevention of complications related
to underinflation and overinflation of Pcuff. Although our
previous study has already suggested beneficial effects of
continuous control of Pcuff in reducing microaspiration
and VAP [18], it was conducted in patients intubated
with PVC-cuffed tracheal tubes. Therefore, these results
could not be generalized to patients intubated with
polyurethane-cuffed tracheal tubes. Further studies with
larger sample size are required in these patients to
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prevention of cuff-related complications such as micro-
aspiration, and VAP.
Some significant differences, including percentage of
time with underinflation and overinflation were found
between patients intubated with tapered-cuffed tracheal
tubes compared with those intubated with cylindrical-
cuffed tracheal tubes. These differences could be explained
by different cuff shape between the two groups. No signifi-
cant effect was found of tracheal cuff shape on microas-
piration of gastric content. However, during continuous
control of Pcuff a trend towards lower pepsin level and
percentage of tracheal aspirates positive for pepsin was
found in patients intubated with tapered-cuffed tracheal
tubes compared with those intubated with cylindrical-
cuffed tracheal tubes. Further, in spite of significantly
higher percentage of time spent with underinflation of
tracheal cuff in patients intubated with tapered-cuffed
tracheal tubes compared with those intubated with cylin-
drical-cuffed tracheal tubes during routine care, microas-
piration of gastric content rate was similar in the two
groups. This result also suggests better sealing with tapered
compared with cylindrical tracheal cuffs. However, our
study was probably underpowered to detect a significant
difference in microaspiration rate between the two groups.
Two recent in vitro studies found tapered-shaped tube
cuff to considerably improve sealing characteristics of
polyvinyl chloride tube cuffs [11,13]. However, no sig-
nificant effect of the tapered-shaped cuff was found in
polyurethane tube cuffs. In contrast, another in vitro
study reported that tapered polyurethane cuff was more
efficient than cylindrical polyurethane cuff in larger
tracheal diameter in preventing fluid leakage [12]. Differ-
ent study design might explain these conflicting results.
In a prospective observational before-after study, our
group found no significant difference in microaspiration
of gastric content between patients intubated with
tapered polyurethane-cuffed tracheal tubes compared
with those intubated with cylindrical polyurethane-cuffed
tracheal tubes [6]. Further clinical studies are required to
determine the impact of tracheal cuff shape on the
incidence of microaspiration, and VAP.
No significant difference was found in airway pressures
between patients intubated with tapered compared with
those intubated with cylindrical tracheal cuffs. Previous
studies demonstrated that Pcuff was tightly correlated
to airway pressure [22,23]. The relatively low airway
pressures found in study patients were similar as those
previously reported in other ICU patients [6,24,25]. This
might strengthen our findings, since these results could
be generalized to patients with similar airway pressure.
Percentage of time spent with underinflation, and
overinflation of Pcuff during continuous control of Pcuff
was not significantly different between patients with highairway pressures and those with lower airway pressures,
suggesting that the pneumatic device is efficient in
patients with high airway pressures, such as those with
severe asthma or ARDS. However, no definite conclu-
sion could be drawn in this subgroup because of the
small number of patients (n = 16).
Our study has some limitations. First, this study was
performed in a single ICU. Therefore, our results could
not be generalized to other ICU patients. Second, our
study did not evaluate the impact of continuous control of
Pcuff on outcomes such as VAP or tracheal injury. How-
ever, in order to adjust for patient-related confounders,
such as tracheal size and aspect, airway pressures, and
tracheal tube size, continuous control and routine care of
Pcuff were performed in the same patient. Therefore, it was
not possible to evaluate these outcomes. Further, it was
mandatory to evaluate the efficiency of the device in
controlling Pcuff before performing studies on its impact
on prevention of complications. Finally, randomization for
tracheal cuff shape was performed per period and not per
patient. However, intubation is often an urgent procedure.
Therefore, it is very difficult to perform randomization
per patient in such a study. In addition, the impact of cuff
shape on microaspiration was a secondary outcome.
Conclusion
We conclude that the pneumatic device is efficient in
controlling Pcuff in critically ill patients intubated with
polyurethane-cuffed tracheal tube. Further studies are
needed to determine the impact of continuous control
of Pcuff and tracheal cuff shape on microaspiration, VAP,
and tracheal injury.
Key messages
 The pneumatic device is efficient in controlling
Pcuff in critically ill patients intubated with
polyurethane-cuffed tracheal tube.
 Conical cuff shape could be beneficial in preventing
microaspiration in critically ill patients.
 Further studies are needed to determine the impact
of continuous control of Pcuff and tracheal cuff
shape on microaspiration, and VAP in patients
intubated with polyurethane-cuffed tracheal tubes.
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